rTMS Efficacy Coupled With Mirror Therapy (STIRM)
Neuropathic Pain
About this trial
This is an interventional treatment trial for Neuropathic Pain focused on measuring transcranial magnetic stimulation, virtual reality, mirror therapy, brain networks, predictive model
Eligibility Criteria
Inclusion Criteria:
- Clinical symptoms typical of neuropathic pain
- Refractory to drug therapies
- Lasting for at least 6 months, with a moderate to severe pain intensity (≥4/10 on Visual Analog Scale, VAS) and a stable pain treatment since 1month at least
- Having right to health benefits
Exclusion Criteria:
- Ferromagnetic components and implanted microprocessors (i.e. cochlear implants)
- Drug-resistant or active epilepsy, pacemaker, pregnancy, ongoing depression or personality troubles, and ongoing opioid treatment.
- Any other contraindications to MRI scanner (e.g., claustrophobia, etc.).
Sites / Locations
- Hôpital Neurologique Pierre Wertheimer
- Centre Hospitalier Universitaire de Saint-EtienneRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Sham Comparator
rTMS active and active mirror-based therapy using virtual reality
rTMS active and sham mirror-based therapy using virtual reality
The patient will have an amount of 4 sessions (S3, S5, S7 and S9) for 1.5 months: 1 session every 2 weeks. The patient will receive rTMS active and active mirror-based therapy using virtual reality.
The patient will have an amount of 4 sessions (S3, S5, S7 and S9) for 1.5 months: 1 session every 2 weeks. The patient will receive rTMS active and sham mirror-based therapy using virtual reality.